Ulhas Kamath, Deputy Managing Director of Jyothy Laboratories, told CNBC-TV18 that contrary to the market speculations, the company is not looking at acquiring the Indian assets of Henkel AG. “We have our own plans on organic growth and we are not looking at Henkel as an asset in our portfolio,” he asserts.
first published: Feb 17, 2011 01:40 pm
A collection of the most-viewed Moneycontrol videos.

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live

Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live

Small-Caps & Risk: What Investors Often Miss

Nifty’s Best Case Target & Top Stock Bets For 2026| IPO Wave Set To Get Bigger| Opening Bell Live
You are already a Moneycontrol Pro user.

